BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24104749)

  • 21. Cancer vaccines: Material breach.
    Dolgin E
    Nature; 2013 Dec; 504(7480):S16-7. PubMed ID: 24352360
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancer vaccines and immunotherapy.
    Tang H
    Hum Vaccin; 2009 Oct; 5(10):666. PubMed ID: 19855174
    [No Abstract]   [Full Text] [Related]  

  • 23. Introduction: Cancer Immunology Special Issue-Immunotherapy.
    Kawakami Y
    Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100
    [No Abstract]   [Full Text] [Related]  

  • 24. Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives.
    Chen X; Yang J; Wang L; Liu B
    Theranostics; 2020; 10(13):6011-6023. PubMed ID: 32483434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promising Immuno-Oncology Options for the Future: Cellular Therapies and Personalized Cancer Vaccines.
    Solomon BJ; Beavis PA; Darcy PK
    Am Soc Clin Oncol Educ Book; 2020 May; 40():1-6. PubMed ID: 32412805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive imaging in cancer immunotherapy: The way to precision medicine.
    Du Y; Qi Y; Jin Z; Tian J
    Cancer Lett; 2019 Dec; 466():13-22. PubMed ID: 31499119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer research: Promise of protection.
    Chi KR
    Nature; 2011 Mar; 471(7339):537-8. PubMed ID: 21438188
    [No Abstract]   [Full Text] [Related]  

  • 28. The cancer vaccine roller coaster.
    Goldman B; DeFrancesco L
    Nat Biotechnol; 2009 Feb; 27(2):129-39. PubMed ID: 19204689
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.
    Bot A; Ahn M; Bosch M; Brockstedt D; Butterfield LH; Cornforth A; Harrop R; Kast WM; Koya R; Marincola F; Margolin K; McCoy C; Pawelec G; Rothman J; Ramirez-Montagut T; Schlom J; Srivastava P; Wallis S; Walter S; Wang E; Waslif J
    J Transl Med; 2012 Nov; 10():218. PubMed ID: 23127127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations.
    Gatti-Mays ME; Redman JM; Collins JM; Bilusic M
    Hum Vaccin Immunother; 2017 Nov; 13(11):2561-2574. PubMed ID: 28857666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach.
    Kim CG; Sang YB; Lee JH; Chon HJ
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA ligandome tumor antigen discovery for personalized vaccine approach.
    Rammensee HG; Singh-Jasuja H
    Expert Rev Vaccines; 2013 Oct; 12(10):1211-7. PubMed ID: 24090147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends and challenges in immuno-oncology trials.
    Kiernan B
    Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
    Shi T; Song X; Wang Y; Liu F; Wei J
    Front Immunol; 2020; 11():683. PubMed ID: 32411132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards personalized, tumour-specific, therapeutic vaccines for cancer.
    Hu Z; Ott PA; Wu CJ
    Nat Rev Immunol; 2018 Mar; 18(3):168-182. PubMed ID: 29226910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer vaccines: what do we need to measure in clinical trials?
    Kudrin A
    Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.
    Finnigan JP; Rubinsteyn A; Hammerbacher J; Bhardwaj N
    Oncology (Williston Park); 2015 Dec; 29(12):970-2, 974-5. PubMed ID: 26676902
    [No Abstract]   [Full Text] [Related]  

  • 38. Precision Medicine-Enabled Cancer Immunotherapy.
    Lee JK; Priceman SJ
    Cancer Treat Res; 2019; 178():189-205. PubMed ID: 31209846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New era of regulatory T cells in tumor immunity: insights in cancer immunotherapy.
    Sheu BC; Chang WC; Huang SC
    J Formos Med Assoc; 2010 Jan; 109(1):1-3. PubMed ID: 20123581
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in Cancer Therapy: Immunotherapies.
    Marmé D
    Oncol Res Treat; 2016; 39(6):324-5. PubMed ID: 27260772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.